questionsmedicales.fr
Composés chimiques organiques
Composés du soufre
Acides du soufre
Acides sulfoniques
Acides arènesulfoniques
Arènesulfonates
Benzènesulfonates
1,2-Dihydroxy-benzène-3,5-disulfonate de disodium
1,2-Dihydroxy-benzène-3,5-disulfonate de disodium : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "1,2-Dihydroxy-benzène-3,5-disulfonate de disodium : Questions médicales les plus fréquentes",
"headline": "1,2-Dihydroxy-benzène-3,5-disulfonate de disodium : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les 1,2-Dihydroxy-benzène-3,5-disulfonate de disodium : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-12",
"dateModified": "2025-03-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "1,2-Dihydroxy-benzène-3,5-disulfonate de disodium"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Benzènesulfonates",
"url": "https://questionsmedicales.fr/mesh/D001557",
"about": {
"@type": "MedicalCondition",
"name": "Benzènesulfonates",
"code": {
"@type": "MedicalCode",
"code": "D001557",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.645.600.080.050.100"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "1,2-Dihydroxy-benzène-3,5-disulfonate de disodium",
"alternateName": "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt",
"code": {
"@type": "MedicalCode",
"code": "D014013",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Alexis Pinet",
"url": "https://questionsmedicales.fr/author/Alexis%20Pinet",
"affiliation": {
"@type": "Organization",
"name": "BioCIS , Université Paris-Sud, CNRS, Université Paris-Saclay , Chatenay-Malabry 92290 , France."
}
},
{
"@type": "Person",
"name": "Bruno Figadère",
"url": "https://questionsmedicales.fr/author/Bruno%20Figad%C3%A8re",
"affiliation": {
"@type": "Organization",
"name": "BioCIS , Université Paris-Sud, CNRS, Université Paris-Saclay , Chatenay-Malabry 92290 , France."
}
},
{
"@type": "Person",
"name": "Laurent Ferrié",
"url": "https://questionsmedicales.fr/author/Laurent%20Ferri%C3%A9",
"affiliation": {
"@type": "Organization",
"name": "BioCIS , Université Paris-Sud, CNRS, Université Paris-Saclay , Chatenay-Malabry 92290 , France."
}
},
{
"@type": "Person",
"name": "Kazuto Ikemoto",
"url": "https://questionsmedicales.fr/author/Kazuto%20Ikemoto",
"affiliation": {
"@type": "Organization",
"name": "Niigata Research Laboratory, Mitsubishi Gas Chemical Co, Inc., Niigata, Japan."
}
},
{
"@type": "Person",
"name": "Hidehiro Uekusa",
"url": "https://questionsmedicales.fr/author/Hidehiro%20Uekusa",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, School of Science, Tokyo Institute of Technology, Tokyo 152-8551, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A New Wavelet-Based Privatization Mechanism for Probability Distributions.",
"datePublished": "2022-05-14",
"url": "https://questionsmedicales.fr/article/35632152",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/s22103743"
}
},
{
"@type": "ScholarlyArticle",
"name": "Causal effect of obesity on the probability of employment in women in Turkey.",
"datePublished": "2023-08-22",
"url": "https://questionsmedicales.fr/article/37651829",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ehb.2023.101301"
}
},
{
"@type": "ScholarlyArticle",
"name": "Biased computation of probability of target attainment for antimicrobial drugs.",
"datePublished": "2023-04-06",
"url": "https://questionsmedicales.fr/article/37025064",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/psp4.12929"
}
},
{
"@type": "ScholarlyArticle",
"name": "Scene memories are biased toward high-probability views.",
"datePublished": "2022-08-18",
"url": "https://questionsmedicales.fr/article/35980704",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/xhp0001045"
}
},
{
"@type": "ScholarlyArticle",
"name": "Probability of sporadic lymphangioleiomyomatosis in women presenting with spontaneous pneumothorax.",
"datePublished": "2023-07-06",
"url": "https://questionsmedicales.fr/article/37415209",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13023-023-02784-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés du soufre",
"item": "https://questionsmedicales.fr/mesh/D013457"
},
{
"@type": "ListItem",
"position": 4,
"name": "Acides du soufre",
"item": "https://questionsmedicales.fr/mesh/D013456"
},
{
"@type": "ListItem",
"position": 5,
"name": "Acides sulfoniques",
"item": "https://questionsmedicales.fr/mesh/D013451"
},
{
"@type": "ListItem",
"position": 6,
"name": "Acides arènesulfoniques",
"item": "https://questionsmedicales.fr/mesh/D017739"
},
{
"@type": "ListItem",
"position": 7,
"name": "Arènesulfonates",
"item": "https://questionsmedicales.fr/mesh/D001190"
},
{
"@type": "ListItem",
"position": 8,
"name": "Benzènesulfonates",
"item": "https://questionsmedicales.fr/mesh/D001557"
},
{
"@type": "ListItem",
"position": 9,
"name": "1,2-Dihydroxy-benzène-3,5-disulfonate de disodium",
"item": "https://questionsmedicales.fr/mesh/D014013"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : 1,2-Dihydroxy-benzène-3,5-disulfonate de disodium - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur 1,2-Dihydroxy-benzène-3,5-disulfonate de disodium",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur 1,2-Dihydroxy-benzène-3,5-disulfonate de disodium",
"description": "Comment le 1,2-Dihydroxy-benzène-3,5-disulfonate est-il utilisé en diagnostic ?\nQuels tests nécessitent ce composé ?\nY a-t-il des tests spécifiques pour évaluer son efficacité ?\nComment évaluer les réactions allergiques au produit ?\nQuelles sont les contre-indications au diagnostic avec ce produit ?",
"url": "https://questionsmedicales.fr/mesh/D014013?mesh_terms=Probability&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur 1,2-Dihydroxy-benzène-3,5-disulfonate de disodium",
"description": "Quels symptômes peuvent survenir après l'administration ?\nComment reconnaître une réaction allergique ?\nLes effets secondaires sont-ils fréquents ?\nQuels signes d'intolérance au produit ?\nY a-t-il des symptômes graves à surveiller ?",
"url": "https://questionsmedicales.fr/mesh/D014013?mesh_terms=Probability&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur 1,2-Dihydroxy-benzène-3,5-disulfonate de disodium",
"description": "Comment prévenir les réactions allergiques ?\nDes tests préalables sont-ils recommandés ?\nQuelles précautions avant l'administration ?\nY a-t-il des recommandations alimentaires ?\nComment informer le personnel médical ?",
"url": "https://questionsmedicales.fr/mesh/D014013?mesh_terms=Probability&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur 1,2-Dihydroxy-benzène-3,5-disulfonate de disodium",
"description": "Quel traitement en cas de réaction allergique ?\nComment gérer les effets secondaires ?\nY a-t-il un antidote pour ce composé ?\nQuand consulter un médecin après administration ?\nDes traitements préventifs existent-ils ?",
"url": "https://questionsmedicales.fr/mesh/D014013?mesh_terms=Probability&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur 1,2-Dihydroxy-benzène-3,5-disulfonate de disodium",
"description": "Quelles complications peuvent survenir ?\nComment gérer une complication grave ?\nY a-t-il des risques à long terme ?\nQuels sont les signes de complications ?\nDes complications spécifiques aux reins ?",
"url": "https://questionsmedicales.fr/mesh/D014013?mesh_terms=Probability&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur 1,2-Dihydroxy-benzène-3,5-disulfonate de disodium",
"description": "Quels sont les facteurs de risque d'allergie ?\nLes personnes âgées sont-elles plus à risque ?\nY a-t-il des risques liés à d'autres médicaments ?\nLes antécédents familiaux influencent-ils le risque ?\nLes maladies préexistantes augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014013?mesh_terms=Probability&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment le 1,2-Dihydroxy-benzène-3,5-disulfonate est-il utilisé en diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est utilisé comme agent de contraste pour améliorer l'imagerie médicale."
}
},
{
"@type": "Question",
"name": "Quels tests nécessitent ce composé ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est souvent utilisé dans les tests d'imagerie par résonance magnétique (IRM)."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests spécifiques pour évaluer son efficacité ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études cliniques évaluent son efficacité en tant qu'agent de contraste."
}
},
{
"@type": "Question",
"name": "Comment évaluer les réactions allergiques au produit ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests cutanés peuvent être réalisés pour détecter des allergies potentielles."
}
},
{
"@type": "Question",
"name": "Quelles sont les contre-indications au diagnostic avec ce produit ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'allergies aux agents de contraste sont des contre-indications."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent survenir après l'administration ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions allergiques, des nausées ou des maux de tête peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des démangeaisons, des éruptions cutanées ou un gonflement peuvent indiquer une allergie."
}
},
{
"@type": "Question",
"name": "Les effets secondaires sont-ils fréquents ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires sont rares mais peuvent survenir chez certains patients."
}
},
{
"@type": "Question",
"name": "Quels signes d'intolérance au produit ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs abdominales ou des vertiges peuvent indiquer une intolérance."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes graves à surveiller ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des difficultés respiratoires nécessitent une attention médicale immédiate."
}
},
{
"@type": "Question",
"name": "Comment prévenir les réactions allergiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un historique médical complet aide à identifier les risques d'allergies."
}
},
{
"@type": "Question",
"name": "Des tests préalables sont-ils recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests cutanés peuvent être effectués pour évaluer le risque d'allergie."
}
},
{
"@type": "Question",
"name": "Quelles précautions avant l'administration ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informer le médecin des allergies antérieures et des médicaments en cours."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations alimentaires ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucune recommandation alimentaire spécifique n'est nécessaire avant l'examen."
}
},
{
"@type": "Question",
"name": "Comment informer le personnel médical ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Communiquer clairement tout antécédent d'allergie ou de réaction indésirable."
}
},
{
"@type": "Question",
"name": "Quel traitement en cas de réaction allergique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'administration d'antihistaminiques ou de corticostéroïdes peut être nécessaire."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets secondaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires légers peuvent être gérés avec des analgésiques et du repos."
}
},
{
"@type": "Question",
"name": "Y a-t-il un antidote pour ce composé ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin après administration ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter si des symptômes graves ou persistants apparaissent après l'administration."
}
},
{
"@type": "Question",
"name": "Des traitements préventifs existent-ils ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antihistaminiques peuvent être administrés avant l'examen pour prévenir les allergies."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des réactions anaphylactiques peuvent survenir, bien que rares."
}
},
{
"@type": "Question",
"name": "Comment gérer une complication grave ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une intervention médicale immédiate est nécessaire en cas de complication grave."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques à long terme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques à long terme sont généralement faibles, mais des études sont en cours."
}
},
{
"@type": "Question",
"name": "Quels sont les signes de complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques, des difficultés respiratoires ou des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Des complications spécifiques aux reins ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications rénales peuvent survenir, surtout chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'allergie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'allergies et les maladies respiratoires augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent avoir un risque accru de réactions indésirables."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques liés à d'autres médicaments ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines interactions médicamenteuses peuvent augmenter le risque d'allergies."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial d'allergies peut augmenter le risque individuel."
}
},
{
"@type": "Question",
"name": "Les maladies préexistantes augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies comme l'asthme peuvent augmenter le risque de réactions."
}
}
]
}
]
}
In this paper, we propose a new privatization mechanism based on a naive theory of a perturbation on a probability using wavelets, such as a noise perturbs the signal of a digital image sensor. Wavele...
This study aims to investigate the causal effect of obesity on the employment probability of women in Turkey via the instrumental variable approach by using data from the 2018 Turkey and Demographic H...
The medical literature is replete with articles in which there is confusion between "free concentration" and "unbound fraction" (f...
Visual scenes are often remembered as if they were observed from a different viewpoint. Some scenes are remembered as farther than they appeared, and others as closer. These memory distortions-also kn...
Sporadic lymphangioleiomyomatosis (S-LAM) is a rare low-grade neoplasm of young women characterized by multiple pulmonary cysts leading to progressive dyspnea and recurrent spontaneous pneumothorax (S...
Calculations were made by applying the Bayes theorem to published epidemiological data on S-LAM, SP and PSP. Each term of the Bayes equation was determined by meta-analysis, and included: (1) the prev...
The prevalence of S-LAM in the general female population was 3.03 per million (95% confidence interval 2.48, 3.62). The incidence rate of SP in the general female population was 9.54 (8.15, 11.17) per...
The probability of discovering S-LAM at chest CT in women presenting with apparent PSP as first disease manifestation was low (0.3%). Recommending chest CT screening in this population should be recon...
Genome architecture mapping (GAM) is a recently developed methodology that offers the cosegregation probability of two genomic segments from an ensemble of thinly sliced nuclear profiles, enabling us ...
Genes exist in a population in a variety of forms (alleles), as a consequence of multiple mutation events that have arisen over the course of time. In this work we consider a locus that is subject to ...
We determined the fixation probability when all terms up to second order in the...
We have analytically exposed the leading way the probability of fixation, at a locus with multiple alleles, is affected by selection. This result may offer important insights into CDCV traits that hav...
Prognostication of burn injury mortality is challenging. Recent mortality prognostication tools have incorporated the percent of full-thickness surface area (FTSA). We hypothesize that the presence of...
We performed a retrospective review of the National Trauma Data Bank (NTDB) from 2007 to 2019 of adults (≥16 years old) with burn injuries. Variables evaluated included basic demographics, presence of...
75,816 patients met inclusion criteria. When controlling for TBSA, the presence of a full-thickness burn had a relative risk of in-hospital mortality of 1.42 (95% CI 1.09-1.85, p = 0.008). The predict...
The presence of full-thickness burns and the proportion of full-thickness burns independently and significantly increased in-hospital mortality. Therefore, clinicians should utilize prognostication mo...
Population structure has been known to substantially affect evolutionary dynamics. Networks that promote the spreading of fitter mutants are called amplifiers of selection, and those that suppress the...
In this article, we propose two variable selection methods for adjusting the censoring information for survival times, such as the restricted mean survival time. To adjust for the influence of censori...